13F HOLDINGS REPORT
Aquilo Capital Management, LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001591986-24-000006
Total Value
$103.7M
Positions
13
Other Managers
0
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 908,474 | $23.6M | 22.76% |
| 2 | BLUEPRINT MEDICINES CORP | 09627Y109 | 114,600 | $12.4M | 11.91% |
| 3 | ARVINAS INC | ARVN | 428,766 | $11.4M | 11.00% |
| 4 | REGENXBIO INC | RGNX | 906,248 | $10.6M | 10.22% |
| 5 | KYMERA THERAPEUTICS INC | KYMR | 328,743 | $9.8M | 9.46% |
| 6 | SILENCE THERAPEUTICS PLC | SLNCF | 500,214 | $9.5M | 9.16% |
| 7 | MERUS N V | N5749R100 | 148,109 | $8.8M | 8.45% |
| 8 | PRECISION BIOSCIENCES INC | DTIL | 381,803 | $3.7M | 3.58% |
| 9 | BICYCLE THERAPEUTICS PLC | BCYC | 156,692 | $3.2M | 3.06% |
| 10 | REPARE THERAPEUTICS INC | 760273102 | 956,932 | $3.2M | 3.04% |
| 11 | ADICET BIO INC | ACET | 2,531,194 | $3.1M | 2.95% |
| 12 | IMMATICS N.V | IMTX | 200,000 | $2.3M | 2.24% |
| 13 | SUTRO BIOPHARMA INC | STRO | 762,498 | $2.2M | 2.15% |